BDBM50144092 CHEMBL294121::[4-(5-Chloro-1H-indole-2-sulfonyl)-piperazin-1-yl]-[4-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)-phenyl]-methanone

SMILES CN1CCN=C1c1ccc(C(=O)N2CCN(S(=O)(=O)c3cc4cc(Cl)ccc4[nH]3)CC2)cc1

InChI Key InChIKey=XXRNLIZHYPRZMD-UHFFFAOYSA-N

Data  2 KI  7 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 9 hits for monomerid = 50144092   

TargetCoagulation factor X(Human)
Bristol Myers Squibb

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50144092BDBM50144092([4-(5-Chloro-1H-indole-2-sulfonyl)-piperazin-1-yl]...)
Affinity DataKi:  1.90nMAssay Description:Inhibition of factor 10aMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/2/2013
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Bristol Myers Squibb

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50144092BDBM50144092([4-(5-Chloro-1H-indole-2-sulfonyl)-piperazin-1-yl]...)
Affinity DataKi:  1.90nMAssay Description:In vitro inhibitory activity against Coagulation factor X was determinedMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Bristol Myers Squibb

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50144092BDBM50144092([4-(5-Chloro-1H-indole-2-sulfonyl)-piperazin-1-yl]...)
Affinity DataIC50: 5nMAssay Description:In vitro inhibitory activity against Coagulation factor X was determinedMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetKallikrein-1(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50144092BDBM50144092([4-(5-Chloro-1H-indole-2-sulfonyl)-piperazin-1-yl]...)
Affinity DataIC50: 5.80E+3nMAssay Description:In vitro inhibitory activity against kallikrein was determinedMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50144092BDBM50144092([4-(5-Chloro-1H-indole-2-sulfonyl)-piperazin-1-yl]...)
Affinity DataIC50: 1.00E+4nMAssay Description:In vitro inhibitory activity against thrombin was determinedMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetTissue-type plasminogen activator(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50144092BDBM50144092([4-(5-Chloro-1H-indole-2-sulfonyl)-piperazin-1-yl]...)
Affinity DataIC50: 1.00E+4nMAssay Description:In vitro inhibitory activity against tissue type plasminogen activator was determinedMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine protease 1(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50144092BDBM50144092([4-(5-Chloro-1H-indole-2-sulfonyl)-piperazin-1-yl]...)
Affinity DataIC50: 1.00E+4nMAssay Description:In vitro inhibitory activity against trypsin was determinedMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVitamin K-dependent protein C(Human)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50144092BDBM50144092([4-(5-Chloro-1H-indole-2-sulfonyl)-piperazin-1-yl]...)
Affinity DataIC50: 1.00E+4nMAssay Description:In vitro inhibitory activity against activated protein C was determinedMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasminogen(Rat)
Millennium Pharmaceuticals

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50144092BDBM50144092([4-(5-Chloro-1H-indole-2-sulfonyl)-piperazin-1-yl]...)
Affinity DataIC50: 1.00E+4nMAssay Description:In vitro inhibitory activity against plasmin was determinedMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed